DLH Holdings Corp

Análisis de la acción DLH Holdings Corp (DLHC)

$3.610

-0.020 (-0.55%)Al cierre

Loading chart…
Máximo
3.690
Apertura
3.545
Precio medio ponderado por volumen
3.62
Volumen
3.78K
Capitalización
152.43M
Mínimo
3.545
Importe
13.66K
EV/EBITDA, TTM
144.26

DLH Holdings Corp. is a provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies. The Company is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The Company's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, modeling, simulation & training, technology-enabled health solutions, software development, and robotics and unmanned systems.

www.dlhcorp.com

Análisis de IA of DLH Holdings Corp (DLHC)

Comprar

DLH Holdings Corp is a good buy right now, trading at $3.65, which is significantly below its 52-week high of $6.88. The stock has a low forward P/E ratio of 17.45, indicating potential undervaluation, especially given the recent positive news of securing a $250 million U.S. Navy contract. However, the company has reported a concerning net income loss of $16,787,000 in Q3 2026, which poses a risk to its financial stability.

Recomendaciones de analistas (2)

+177.01% de potencial alcista
Comprar
2 Comprar
0 Mantener
0 Vender
Actual: 3.61
Mínimo
10.00
Promedio
10.00
Máximo
10.00

Noble Capital

2026-07-31

Precio objetivo

$7

Superar al mercado

Noble Capital

2025-05-09

Precio objetivo

$10

Superar al mercado

Métricas de valoración

El PER previsto actual de DLH Holdings Corp (DLHC) es 17.45, frente a su media de 5 años de 9.20.

PER previsto

Valor razonable
Media 5A P/E
9.20
P/E actual
17.45
Sobrevalorada
34.86
Infravalorada
-16.46

EV/EBITDA previsto

Muy sobrevalorado
Media 5A EV/EBITDA
15.86
EV/EBITDA actual
144.26
Sobrevalorada
48.31
Infravalorada
-16.58

Precio/ventas previsto

Valor razonable
Media 5A P/S
0.41
P/S actual
0.30
Sobrevalorada
0.55
Infravalorada
0.28

Escenarios de precio de Alphio AI para DLHC

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%DLHC

$5.55

Precio del escenario

B

Base

Base · 50%DLHC

$4.96

Precio del escenario

B

Bajista

Bajista · 25%DLHC

$4.16

Precio del escenario

Cronología de eventos

2026-10-05 (ET)

09:00:00

DLH Holdings Awarded NIH Data Governance Framework Task Order

2026-09-28 (ET)

09:00:00

DLH Holdings Awarded Task Order Worth Up to $19.1M from NIH

2026-09-16 (ET)

09:00:00

DLH Holdings Awarded Task Order Worth $43.7M

2026-06-30 (ET)

16:30:00

DLH Holdings Appoints Kathryn JohnBull as New CEO

2026-06-25 (ET)

16:30:00

DLH Holdings Awarded U.S. Navy Logistics IT Contract Worth $250M

Noticias

Preguntas frecuentes sobre DLHC, respondidas por Alphio AI

DLH Holdings Corp. is a provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies. The Company is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The Company's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, modeling, simulation & training, technology-enabled health solutions, software development, and robotics and unmanned systems. It operates in the Technology sector (SERVICES-HELP SUPPLY SERVICES industry).

DLH Holdings Corp is a good buy right now, trading at $3.65, which is significantly below its 52-week high of $6.88. The stock has a low forward P/E ratio of 17.45, indicating potential undervaluation, especially given the recent positive news of securing a $250 million U.S. Navy contract. However, the company has reported a concerning net income loss of $16,787,000 in Q3 2026, which poses a risk to its financial stability.

2 analysts cover DLHC: 2 rate it Buy, 0 Hold and 0 Sell. The average price target is 10.00.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar